Mitochondrially-targeted therapeutics
Mitochondrially-targeted therapeutics has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Mar 14, 2025: “Telomere length in offspring is determined by mitochondrial-nuclear communication at fertilization”.
1 paper studies it1 findingUpdated
See all 1 papers on mitochondrially-targeted therapeutics
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: Channel 7 Children’s Research Foundation and 1 more
- 1 of 1 finding with company ties
- Animals1
What did studies of mitochondrially-targeted therapeutics find?
1Studies of mitochondrially-targeted therapeutics measured one outcome, neonatal telomere length.
Neonatal telomere length
upin mice1
1 study
Neonatal telomere length
upin mice1
Mitochondrially-targeted therapeutics increase neonatal telomere length in mice (preimplantation telomere resetting).
Animalspreimplantation telomere resetting
Latest
Nature Communications
Telomere length in offspring is determined by mitochondrial-nuclear communication at fertilization
Experiments in miceInterventions